CFTR and congenital bilateral aplasia of vas deferens from CFTR mutation: These results demonstrated that our CAVD population had a lower percentage than previous reports in which 70%–80% of CBAVD patients carried at least one CFTR mutation (Yu et al., 2012; Wang et al., 2020), which may be due to our small sample size.